name,drs_uri,study_short_name,participant_id,File ID,Md5sum,Biospecimen ID,Diagnosis,MedDRA Disease Code,Primary Site,Histology,Stage of Disease,Tumor Grade,Age,Sex,Race,Ethnicity,Carcinogen Exposure,Targeted Therapy,Parent Biospecimen ID,Anatomical Collection Site,Tissue Category,Collection Timepoint,User Comment
MSB-00140-06-genomic-report-CTDCv1,drs://nci-crdc.datacommons.io/dg.4DFC/870175D4-EE9A-4A64-BF7A-6CDDB18C22BD,CMB,MSB-00140,dg.4DFC/870175D4-EE9A-4A64-BF7A-6CDDB18C22BD,dd970cc07d55b06754594e8177826b93,MSB-00140-06,Plasma Cell Myeloma,10028566,Bone Marrow,Plasma cell neoplasm,,,65.0,Female,White,Not Hispanic or Latino,[No],"[Bortezomib, Lenalidomide]",MSB-00140-06,Iliac Crest,,Progression (Fresh),
MSB-00140-06-somatic-mutations-CTDCv1,drs://nci-crdc.datacommons.io/dg.4DFC/CC00EEF6-1730-40B3-9FA6-3D8FCD39EB83,CMB,MSB-00140,dg.4DFC/CC00EEF6-1730-40B3-9FA6-3D8FCD39EB83,e02f606a33fcd21a4358caa740b86457,MSB-00140-06,Plasma Cell Myeloma,10028566,Bone Marrow,Plasma cell neoplasm,,,65.0,Female,White,Not Hispanic or Latino,[No],"[Bortezomib, Lenalidomide]",MSB-00140-06,Iliac Crest,,Progression (Fresh),
